Concept Lead score
Lung Cancer 1 1
Non-Small Cell Lung Cancer 0 0.82
ALK-Positive Non-Small Cell Lung Cancer (NSCLC) 0 0.81
ALK-Positive Lung Cancer 0 0.58
Chemotherapy 0 0.52
Small Cell Lung Cancer 0 0.5
Adjuvant Chemotherapy 0 0.43
Anaplastic Lymphoma Kinase 0 0.41
Biologic Therapy 0 0.4
Cancer 0 0.37
Lung 0 0.37
ALK Inhibitor 0 0.33
Targeted Cancer Therapy 0 0.29
Genomic Medicine 0 0.28
Neoadjuvant Therapy 0 0.21
Food and Drug Administration (FDA) 0 0.09
Plasma 0 0.09
Scan 0 0.09
Surgery 0 0.09
Tumor 0 0.09
Adjuvant Setting 0 0.06
Platinum 0 0.06
Healthcare and Medical Technology 0 0.04
Tyrosine Kinase Inhibitor 0 0.04
Adenocarcinoma 0 0.03
Central Nervous System 0 0.03
Clinical Research 0 0.03
DNA Sequencing 0 0.03
Europe 0 0.03
Immunotherapy 0 0.03
Lymph Node 0 0.03
Medical Oncology 0 0.03
Resection 0 0.03
Tyrosine Kinase 0 0.03
Specialty Lead score
Hematology-Oncology 1 1
Internal Medicine 0 1
Pharmacist 0 1
Pulmonary Medicine 0 1
Diabetes & Endocrinology 0 0.83
Neurology & Neurosurgery 0 0.41
General Surgery 0 0.35
Allergy & Clinical Immunology 0 0.33